Delivery Order SPE2DB20D1110-SPE2DB24FK45W
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.47 firm-fixed-price contract is for the delivery of 180 units of 800 mg delayed-release mesalamine tablets, a medication used to treat gastrointestinal conditions. The contract has an ultimate completion date of October 20, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,860.58 firm fixed-price contract is for the delivery of 120 tablets of the drug mesalamine delayed-release 1.2 gram. The ultimate completion date is June 26, 2025. This award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 180 800-milligram delayed-release mesalamine tablets. The $6,145.71 contract has an ultimate completion date of June 11, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,978.92 firm fixed-price delivery order is for the supply of 120 tablets of 1.2 gram Mesalamine delayed-release tablets. The contract has an ultimate completion date of July 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025 with...
This is a federal delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Mesalamine 800 mg delayed-release tablets, with a ceiling value of $11,775.90 and a performance period through January 2, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,733.84 firm fixed-price contract is for the delivery of 120 tablets of the medication Mesalamine DR 1.2 GM. The contract has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp is the prime contractor, with no major subcontractors identified. The contract is not set aside....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of the medication Mesalamine Delayed-Release 1.2 gram, with a ceiling value of $2,180.50 and a completion date of June 5, 2025. The contract is not set aside for any special designation. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,147.79, is for the delivery of Mesalamine delayed-release 1.2 gram tablets in quantities of 120 tablets per bottle. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablet units of the medication Mesalamine DR 1.2 GM. The contract has a ceiling value of $4,553.87 and is a firm fixed-price delivery order. The period of performance extends to July 10, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine 1.2G 120S, a pharmaceutical product, with a ceiling value of $4,118.76 and a period of performance through May 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...